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A B S T R A C T
Background
Breast cancer is the most common cancer in women worldwide, and is a leading cause of cancer death among women. Prophylactic or
curative mastectomy is often followed by breast reconstruction for which there are several surgical approaches that use breast implants
with which surgeons can restore the natural feel, size and shape of the breast.
Objectives
To assess the effects of different types of breast implants on capsular contracture, surgical short- and long-term complications, postop-
erative satisfaction level and quality of life in women who have undergone reconstructive breast surgery after mastectomy.
Search methods
We searched the Cochrane Breast Cancer Group’s Specialised Register on 20 July 2015, MEDLINE (1985 to 20 July 2015), EMBASE
(1985 to 20 July 2015) and the Cochrane Central Register of Controlled Trials (CENTRAL; Issue 8, 2015). We also searched the
World Health Organization’s International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov on 16 July 2015.
Selection criteria
We included randomised controlled trials (RCTs) and quasi-RCTs that compared different types of breast implants for reconstructive
surgery. We considered the following types of intervention: implant envelope surfaces - texturised versus smooth; implant filler material
- silicone versus saline, PVP-Hydrogel versus saline; implant shape - anatomical versus round; implant volume - variable versus fixed;
brands - different implant manufacturing companies and implant generation (fifth versus previous generations).
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Data collection and analysis
Two review authors independently assessed methodological quality and extracted data. We used standard Cochrane methodological
procedures. The quality of the evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation
(GRADE) system.
Main results
Five RCTs with 202 participants met the inclusion criteria. The women participants were typically in their 50s, and the majority of
them (about 82%) received reconstructive surgery following breast cancer, while the others had reconstructive surgery after prophylactic
mastectomy. The studies were heterogenous in terms of implant comparisons, which prevented us from pooling the data.
The studies were judged as being at an unclear risk of bias for most risk of bias items owing to poor quality of reporting in the trial
publications. Three of the five RCTs were judged to be at high risk of attrition bias, and one at high risk of detection bias.
Textured silicone versus smooth silicone implants: textured implants were associated with worse outcomes when compared to smooth
implants (capsular contracture: risk ratio (RR) 0.82, 95% CI 0.14 to 4.71; 1 study, 20 participants; very low quality evidence; reinterven-
tion: RR 0.82, 95% CI 0.14 to 4.71; 1 study, 20 participants; very low quality evidence). No results in this comparison were statistically
significant.
Silicone versus saline implants: saline-filled implants performed better than silicone-filled implants for some outcomes; specifically,
they produced less severe capsular contracture (RR 3.25, 95% CI 1.24 to 8.51; 1 study, 60 participants; very low quality evidence) and
increased patient satisfaction (RR 0.60, 95%CI 0.41 to 0.88; 1 study, 58 participants; very low quality evidence).However reintervention
was significantly more frequent in the saline-filled implant group than in the silicone-filled group (OR 0.08, 95% CI 0.01 to 0.43; 1
study, 60 participants; very low quality evidence).
Poly(N-vinyl-2-pyrrolidone) hydrogel-filled (PVP-hydrogel) versus saline-filled implants: PVP-hydrogel-filled implants were associated
with worse outcomes when compared to saline-filled implants (capsular contracture: RR 3.50, 95% CI 0.83 to 14.83; 1 study, 40
participants; very low quality evidence; short-term complications: RR 2.10, 95% CI 0.21 to 21.39; 1 study, 41 participants; very low
quality evidence).
Anatomical versus round implants: anatomical implantswere associatedwithworse outcomes than round implants (capsular contracture:
RR 2.00, 95% CI 0.20 to 20.15; 1 study, 36 participants; very low quality evidence; short-term complications: RR 2.00, 95% CI 0.42
to 9.58; 1 study, 36 participants; very low quality evidence; reintervention: RR 1.50, 95% CI 0.51 to 4.43; 1 study, 36 participants; very
low quality evidence). No results in this comparison were statistically significant.
Variable-volume versus fixed-volume implants: data about one-stage reconstruction using variable-volume implants were compared
with data about fixed-volume implants positioned during the second surgical procedure of two-stage reconstructions. Fixed-volume
implant reconstructions were possibly associated with a greater number of women reporting that their reconstruction corresponded
with expected results (RR 0.25, 95% CI 0.10 to 0.62; 1 study, 40 participants; very low quality evidence) and fewer reinterventions (RR
7.00, 95% CI 1.82 to 26.89; 1 study, 40 participants; very low quality evidence) when compared to variable-volume implants. A higher
patient satisfaction level (rated from 1 to 6, with 1 being very bad and 6 being very good) was found with the fixed-volume implants
for overall aesthetic result (mean difference (MD) -1.10, 95% CI -1.59 to -0.61; 1 study, 40 participants; very low quality evidence).
There were no studies that examined the effects of recent (fifth) generation silicone implants versus previous generations or different
implant manufacturing companies.
Authors’ conclusions
Despite the central role of breast reconstruction in women with breast cancer, the best implants to use in reconstructive surgery
have been studied rarely in the context of RCTs. Furthermore the quality of these studies and the overall evidence they provide is
largely unsatisfactory. Some of our results can be interpreted as early evidence of potentially large differences between different surgical
approaches, which should be confirmed in new high-quality RCTs that include a larger number of women. These days - even after a
few million women have had breasts reconstructed - surgeons cannot inform women about the risks and complications of different
implant-based breast reconstructive options on the basis of results derived from RCTs.
P L A I N L A N G U A G E S U M M A R Y
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Different types of implants for reconstructive breast surgery after mastectomy
Review question
We assessed the effects of different types of breast implants on short-term and long-term surgical complications, cosmetic outcomes,
satisfaction with the surgical procedure and the quality of life in women undergoing breast reconstruction following a mastectomy
(breast removal).
Background
An estimated 28% to 60% of women affected by breast cancer will undergo a mastectomy (i.e. surgical removal of the breast). Following
a mastectomy, women can choose from many breast reconstruction options and achieve a natural feel with appropriate size and shape
of the breast, according to individual needs. These reconstruction options are also available for the increasing number of women at high
risk of developing hereditary breast cancer who undergo risk-reducing mastectomy. Options include implants that are silicone-filled
(filled with an inert, man-made polymer in gel form), saline-filled (a silicone shell, filled with sterile salt water), anatomically shaped
or round, textured or smooth, and of fixed-volume or variable-volume. We wanted to examine if different types of breast implants are
associated with better or worse surgical outcomes and patient satisfaction.
Study characteristics
The evidence is current to July 2015. We conducted a review to compare short- and long-term surgical complications (such as scar
tissue forming around the implant and squeezing it - referred to as ’capsular contracture’, and ’implant rupture’), cosmetic outcomes,
women’s postoperative quality of life and satisfaction with different types of breast implants used in breast reconstruction. We found
five randomised studies involving 202 women that provided data for five different comparisons: rough versus smooth surface, implant
filler materials compared to each other (silicone versus saline, and hydrogel versus saline), anatomical versus round shape, and variable-
versus fixed-volume. Four studies included women who received a mastectomy for breast cancer and one study included women who
had bilateral mastectomies for preventive purposes.
The authors of two studies reported that they did not have competing interests; the authors of three studies did not report this
information. Three studies reported that their studies received financial support from research foundations; the other studies did not
report any information regarding the source of their funding.
Key results
Only two studies reported differences between types of implants for some of the outcomes we considered.
One study on 65 women compared silicone-filled implants with saline-filled implants and showed that saline implants resulted in fewer
cases of capsular contracture and a higher number of women who were satisfied with the reconstructed breast. However more women
in the saline-filled implant group required further operations on the reconstructed breast than in the silicone-filled implant group.
Another study on 40 women compared variable-volume implants (inserted in a single surgical procedure) with fixed-volume implants
(inserted in the second of two separate surgical procedures) and showed that there were significantly higher satisfaction levels and
significantly lower reoperation rates with the fixed-volume implants.
The remaining three studies reported on the following comparisons: rough versus smooth silicone-filled implants (20 women), PVP-
hydrogel versus saline-filled implants (41 women) and anatomically shaped versus round implants (36 women). These studies reported
no differences between implant types for outcomes such as capsular contracture, other short-term complications or reoperation rates.
There were no studies that compared recent generation silicone implants with earlier versions or implants from different manufacturing
companies.
Quality of the evidence
The evidence we found was limited: only a negligible, tiny fraction of women who undergo breast reconstruction have been studied
in randomised controlled trials. The quality of evidence is very low, as the studies we identified suffered from major methodological
limitations.
Despite the fact that several million women have had their breasts reconstructed over the last 20 years, the small number of studies
and the low numbers of women included in these studies does not allow us to draw any definitive conclusions about the which is the
best type of breast implant. This lack of evidence should be discussed when informing women about the risks and complications of
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different implant-based breast reconstruction options. There is a need for further studies, which include a larger number of women
and compare different types of implants, to free women from decisions made on the basis of surgical opinion alone.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Textured versus smooth implants for reconstructive breast surgery
Patient or population: women having reconstruct ive breast surgery
Settings: cancer centres
Intervention: textured implants
Comparison: smooth implants
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Smooth implants Textured implants
Capsular contracture
Number of women with
capsular contracture
Follow-up: mean 3
years
Study population RR 0.82
(0.14 to 4.71)
20
(1 study)
⊕©©©
very low1,2
222 per 1000 182 per 1000
(31 to 1000)
M oderate
222 per 1000 182 per 1000
(31 to 1000)
Reintervention
Number of women with
reintervent ions
Follow-up: mean 3
years
Study population RR 0.82
(0.14 to 4.71)
20
(1 study)
⊕©©©
very low1,2
222 per 1000 182 per 1000
(31 to 1000)
M oderate
222 per 1000 182 per 1000
(31 to 1000)
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* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RR: risk rat io
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1We downgraded twice based on unclear risk of select ion, performance and detect ion bias.
2We downgraded once because the result was based on only one study with 20 part icipants.
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B A C K G R O U N D
Description of the condition
Breast cancer is the most common cancer in women worldwide
(excluding cancers of the skin), and represents the second leading
cause of cancer death among women (after lung cancer) in high-
income countries (American Cancer Society 2014; Siegel 2015).
Since the 1940s, the incidence of breast cancer has gradually in-
creased inWestern countries at a rate of approximately 1%per year
(Boyle 2005). Despite this increase, mortality from breast cancer
has declined in countries with organised, population-based mam-
mography screening (Jonsson 2007), even if trials with optimal
randomisation do not show a significant reduction in breast can-
cer mortality and although substantial over-diagnosis and over-
treatment cannot be ruled out (Gøtzsche 2013). New and effi-
cient therapeutic regimens have led to the prolonged survival of
women and an improved quality of life (Hortobagyi 2005). These
interventions have increased the number of breast cancer survivors
considerably; a further increase of 31% is expected in the 10-year
period between 2005 and 2015 (De Angelis 2009).
Novel approaches in oncological breast surgery and new technolo-
gies in the global management of women diagnosed with breast
cancer will allow patients to access the best, individually tailored
treatment (Cordeiro 2008). Nevertheless, an estimated 28% to
60% of women affected by breast cancer will undergo a mastec-
tomy (McGuire 2009). Breasts represent a strong symbol of femi-
ninity, the loss of which can lead to important psychological conse-
quences that potentially damage a woman’s self-image and leading
her to question her desirability as a sexual partner (Marin-Gutzke
2010). Following a surgical procedure to remove breast cancer,
women face the challenge of deciding what to do about breast
reconstruction.
After oncological surgery for breast cancer, women can choose
from many options for breast reconstruction in order to achieve
a reconstructed breast that has a natural feel combined with a
size and shape that meets their individual needs (Djohan 2008;
Thiruchelvam 2013). Women also have the option of deciding
which type of breast reconstruction they prefer, and can select
alternative measures, such as external prostheses.
The same reconstructive options are available for the increasing
number of women who undergo risk-reducing mastectomy be-
cause they are at high risk of developing breast cancer (i.e. hered-
itary breast cancer) (Nelson 2012).
Women who undergo a mastectomy should be aware of all avail-
able reconstructive options and should discuss the benefits and
limitations of each technique with their physician and plastic sur-
geon before making decisions about the best course of action.
Description of the intervention
The demand for reconstructive breast surgery is increasing among
women: The number of procedures performed in the USA pre-
sented a 30% increase over the last decade, from 78,800 in 2000
to nearly 102,200 procedures in 2014, according to the American
Society of Plastic Surgeons (ASPS 2014).
Breast reconstruction can be performed at the same time that the
oncological procedure is carried out to remove the breast cancer
(immediate reconstruction), or it can be delayed until all adjuvant
treatments have been completed (postoperative chemotherapy or
radiotherapy) (Champaneria 2012; D’Souza 2011).
Both immediate and delayed reconstruction can be performed us-
ing autologous tissue (i.e. tissue used for surgical reconstruction
that comes from the patient’s own body, such as the musculocu-
taneous pedicle or free flaps) or using implants. Reconstruction
with implants can occur in a one-stage (direct-to-implant recon-
struction) or two-stage (tissue expander followed by permanent
implant) intervention. The one-stage reconstruction option has
been improved by the recent introduction of meshes (biological
or synthetic) in breast surgery (Ho 2012).
Implant-based breast reconstruction usually involves the place-
ment of breast implants filled with silicone gel or saline. The best
results with implant-based reconstruction are achieved in patients
with small or moderate breast volume and a low degree of ptosis
(i.e. age-related drooping) due to easier achievable symmetry be-
tween natural and reconstructed breasts (Spear 2007).
Five generations of silicone breast implants have been developed
since silicon implants were introduced in 1961 (Blocksma 1965),
each leading to better results in terms of both short- and long-
term surgical and aesthetic outcomes (Champaneria 2012).
While silicone implants are now routinely used in breast surgery,
they have been the subject of controversy. This was particularly
true in the USA, where there was a moratorium on their use from
1992 to 2006 due to safety concerns. Following subsequent sci-
entific validation of their safety, silicone implants have regained
widespread acceptance for clinical use (Chao 2016).
How the intervention might work
Implant-based breast reconstruction allows restoration of a
woman’s lost physical image with excellent cosmetic results (Spear
2007).
Moreover, breast implant positioning after a mastectomy repre-
sents a minimally invasive procedure compared with autologous
tissue breast reconstruction, and carries no risk of distant donor
site-related morbidity (Jewell 2012).
However, the use of breast implants can be associated with some
short- and long-term complications, including capsular contrac-
ture (i.e. development of problems caused by scar tissue), infec-
tion, haematoma (collection of clotted blood), seroma (collection
of fluid), rupture of the implant, and migration of the filler mate-
rial (Accurso 2008; Barnsley 2006; Henriksen 2003). These com-
plications can lead to reinterventions to replace the implant, which
7Different types of implants for reconstructive breast surgery (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
result in additional costs to the patient, potentially suboptimal
results, and a higher probability of repeated adverse events (Baker
1978; Nahabedian 2009a).
In particular, capsular contracture can span from simple breast in-
duration (hardening) to the development of a painful breast, with
total distortion of its shape and volume. This can severely compro-
mise the aesthetic outcome, and is the most significant reason for
patient dissatisfaction following breast implant surgery (Handel
2006; Nahabedian 2009b). Capsular contracture rates after breast
reconstruction range from 4% to 17% (Spear 2007). Radiother-
apy increases the risk of complications by more than 40% in pros-
thetic-based reconstructions, increasing the rate of capsular con-
tractures to between 25% and 30% of patients (Kronowitz 2009;
Nava 2011).
In addition, different types of implants (e.g. textured, smooth,
silicone- or saline-filled) exhibit different rates of complications
(Hammond 2012; Maxwell 2012), although no consensus has
been reached about the best type of implant-based reconstruction.
Women undergoing this type of surgery should be aware of all of
the possible complications and pitfalls related to these procedures.
Why it is important to do this review
Breast cancer control represents a major objective in public health,
and breast reconstruction following oncological procedures is one
of the main health objectives of the European Community for the
coming years (EU 2012). The European Society of Breast Cancer
Specialists (EUSOMA) has defined the requirement for specialist
breast units, and stressed the importance of reconstruction after
oncological surgery (EUSOMA 2012).
Since surgical techniques for breast reconstruction are almost
standardised worldwide (Nahabedian 2009b; Querci della Rovere
2010), researchers’ efforts should be directed at finding evidence
of the best implants in terms of patient satisfaction, postoperative
quality of life, women’s safety, and cosmetic outcomes.
There are currently no systematic reviews in the scientific literature
on this topic.
O B J E C T I V E S
To assess the effects of different types of breast implants on capsu-
lar contracture, surgical short- and long-term complications, post-
operative satisfaction level and quality of life in women who have
undergone reconstructive breast surgery after mastectomy.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered any randomised or quasi-randomised controlled
trials (RCTs or qRCTs) that compared different types of breast
implants.Quasi-randomised trialswere defined as those presenting
a predictable non-concealed allocation (e.g. simple alternation,
date of birth, hospital admission number).
Types of participants
Women undergoing reconstructive breast surgery with implants
following mastectomy for treatment of breast cancer or for risk
reduction.
Types of interventions
Different types of breast implants and different surgical procedures
for reconstructive purposes.
We compared:
• implant envelope surfaces: texturised versus smooth;
different types of texturisation;
• implant filler material: silicone versus saline; poly(N-vinyl-
2-pyrrolidone) hydrogel-filled (PVP-hydrogel) versus saline;
• implant shape: anatomical versus round;
• implant volume: variable versus fixed;
• brands: different implant manufacturing companies;
• implant generation: fifth versus previous generations of
silicone implants.
We excluded the data from trials if flaps or other interventions
(except oncological excisions) were performed along with implant
positioning.
We planned to perform cross-comparisons if the number of par-
ticipants in each group allowed it.
Types of outcome measures
Primary outcomes
• Capsular contracture rate and severity.
◦ If assessed by a surgeon, we used Baker, Gylbert, and
Spear classifications to identify contracture severity at a
minimum of one year of follow-up (Baker 1978; Gylbert 1989;
Spear 1995).
◦ We considered participants’ subjective self-
assessments, or objective measurements of firmness (applanation
tonometry), as other valid methods of identifying contracture
severity at a minimum of one year of follow-up.
• Participant-reported outcomes: postoperative quality of life
(psychosocial, physical, and sexual well-being) or satisfaction
level (satisfaction with breast and reconstructive outcome), as
measured by BREAST-Q, EORTC QLQC30 (Br23), and 36-
Item Short-Form Health Survey (SF-36).
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Secondary outcomes
• Implant rupture and filler material migration rates.
◦ We considered migration of filler material as evidence
of filler material outside the capsule surrounding the implant that
was visible during magnetic resonance imaging (MRI) or surgery.
• Short-term complication rates: implant infection, seroma,
haematoma, implant extrusion, and implant malpositioning.
• Reintervention and long-term complication rates: late
seroma (i.e. seroma presenting more than one month after
surgery), double-capsule formation (i.e. the presence of a double-
layered capsule surrounding the implant at reintervention), and
chronic pain (i.e. pain that persists for more than three months
after surgery).
• Cosmetic outcomes not reported by participants (i.e.
evaluation of reconstructive outcomes, e.g. breast shape and
symmetry, by the operating surgeon or by other clinicians).
Search methods for identification of studies
Electronic searches
We searched the following databases.
• The Cochrane Breast Cancer Group’s Specialised Register.
Details of the search strategies used by the Group for the
identification of studies and the procedure used to code
references are outlined in the Group’s module (http://
www.mrw.interscience.wiley.com/cochrane/clabout/articles/
BREASTCA/frame.html). Trials with the key words “breast
reconstruction,” “breast reconstructive surgery,” “implant-based
breast reconstruction,” “mammaplasty,” “silicone implant,”
“saline implant,” “silicone breast implant,” “saline breast
implant,” “breast implants,” “implants,” “silicone,” “saline,”
“texturized implant,” “smooth implant,” “variable volume
implant,” and “fixed volume implant” were extracted and
considered for inclusion in the review.
• MEDLINE (via Ovid SP; from 1985 until 20 July 2015).
See Appendix 1.
• EMBASE (via EMBASE.com; from 1985 until 20 July
2015). See Appendix 2.
• The Cochrane Central Register of Controlled Trials
(CENTRAL; Issue 8, 2015). See Appendix 3.
• The World Health Organization (WHO) International
Clinical Trials Registry Platform (ICTRP) search portal (http://
apps.who.int/trialsearch/Default.aspx) for all prospectively
registered and ongoing trials on 16 July 2015. See Appendix 4.
• Clinicaltrials.gov (http://clinicaltrials.gov/) on 16 July
2015. See Appendix 5.
Searching other resources
We tried to identify further studies by reviewing reference lists of
relevant trials or reviews. We obtained a copy of the full article for
each reference that reported a potentially eligible trial. When this
was not possible, we attempted to contact study authors to request
additional information.
Data collection and analysis
Selection of studies
We screened all abstracts identified by the search strategies de-
scribed above for duplicates. Then two independent review au-
thors (CR and NR) assessed the deduplicated abstracts to exclude
studies that did not meet the inclusion criteria. Disagreements
were resolved through discussion between the two review authors;
in cases of persistent disagreement, they consulted a third review
author (ST). The full publications of all potentially relevant ab-
stracts were obtained and formally assessed for inclusion. Trials in
languages other than English were included as well. Review au-
thors were not blinded to the names of the study authors, their
corresponding institutions, the journal of publication, or the re-
sults.
Data extraction and management
We developed a tailored data extraction form to record the follow-
ing details of the studies.
• Methods: study design, year, country, language, duration,
sequence generation, allocation concealment, blinding.
• Participants: source of participants, demographic
characteristics, inclusion/exclusion criteria, numbers of
participants at baseline and completion, setting.
• Interventions and controls: number of arms, definitions of
interventions, materials, surgical techniques, timing of surgery.
• Outcomes: list of assessed outcomes, definition of each
outcome, outcome assessor, blinding of the assessor.
• Results: follow-up data, analyses (intention-to-treat or per-
protocol), withdrawals, and losses to follow-up.
Data were extracted independently by two review authors (LI and
ST); differences of opinion between these review authors were re-
solved through discussion with a third review author (LM). Miss-
ing or updated information was sought through contact with the
study authors.
Quantitative data from trials with more than one publication were
extracted from all publications; the most recent publication was
considered as the primary reference.
All data were managed by using the Review Manager Software
version 5.2 (RevMan 2012).
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Assessment of risk of bias in included studies
Two review authors independently evaluated each study for risk
of bias using the criteria recommended in the Cochrane Handbook
for Systematic Reviews of Interventions for the domains of sequence
generation; allocation concealment; blinding of health profession-
als, participants, and outcome assessors; incomplete outcome data;
selective outcome reporting; and other potential threats to validity
(Higgins 2011d). Each domain was judged as having a low, high
or unclear risk of bias. We compared the judgements and resolved
any inconsistencies in the assessments.
Sequence generation for randomisation
We assessed randomisation as being at low risk of bias if the proce-
dure for sequence generation was explicitly described and was con-
sidered likely to produce comparable groups. Examples of suitable
methods include computer-generated randomnumbers, a random
numbers table, and coin tossing. If no description was given, we
contacted the study authors, and if no response was received, we
made a judgment of unclear risk of bias. With regard to our inclu-
sion criteria for this review, if a response suggested that a study was
not randomised, we excluded it. If the study used a predictable al-
location (e.g. simple alternation, date of birth, hospital admission
number) it was rated as being at high risk of bias for this domain.
Allocation concealment
We assessed concealment of treatment allocation as being at low
risk of bias if the procedure was explicitly described and was con-
sidered likely to ensure that intervention allocations could not have
been foreseen in advance of, or during, enrolment. Examples of
suitable methods include centralised randomisation, numbered or
coded containers, and sealed, opaque envelopes. Procedures with
a high risk of bias include alternation and references to case record
numbers or dates of birth. If no description was given, we con-
tacted study authors; if no response was received, we made a judg-
ment of unclear risk. If allocation was not concealed, we made a
judgment of high risk of bias for this domain.
Blinding of health professionals, participants, and outcome
assessors
In this context, surgeons are not usually blinded to the surgical
procedure and associated elements (e.g. type of implant). We as-
sessed the risk of bias associatedwith blinding of health profession-
als and participants primarily on the basis of the likelihood that
such blinding was sufficient to ensure that caregivers and women
had no knowledge of which intervention had been received.
Even if the surgeon could not be blinded, it is possible that the
healthcare professionals who followed participants after the pro-
cedure could have been blinded, and contact between other care-
givers and the surgeon could have been avoided. Other blinding
techniques that we evaluatedwere those inwhich participants were
instructed that they should not tell outcome assessors the surgery
received.
For each included study we described the methods used, if any, to
blind the outcome assessor from knowledge of which intervention
a participant received.We judged studies to be at low risk of bias if
the outcome assessors were blinded, or if we ascertained that lack
of blinding may not have affected the results. If authors stated that
blindingwas not possible because of the nature of the intervention,
we judged the study to be at high risk of bias because it is possible
that lack of blinding influenced the results. Blinding of health
professionals was signalled if reported.
If no description was given, we contacted study authors, and if no
response was received, we made a judgment of unclear risk.
Incomplete outcome data
Incomplete outcome data included attrition, exclusions, andmiss-
ing data.
We made a judgement of low risk of bias if participants included
in the analysis were exactly those who had been randomly as-
signed into the trial, and if missing outcome data were balanced
in numbers across intervention groups, with similar reasons for
missing data across groups, or if no outcome data were missing.
We made a judgement of low risk of bias if, for dichotomous out-
come data, the proportion of missing outcomes compared with
observed event risk was not enough to have a clinically relevant
impact on the intervention effect estimate; and for continuous
outcome data, when plausible effect size (difference in means or
standardised difference in means) among missing outcomes was
not enough to have a clinically relevant impact on observed effect
size; or if missing data had been imputed using appropriate meth-
ods.
We made a judgement of high risk of bias for any of the follow-
ing: when reasons for missing outcome data were likely to be re-
lated to the true outcome, with imbalance in numbers or reasons
for missing data across intervention groups; for dichotomous out-
come data, when the proportion of missing outcomes compared
with observed event risk was enough to induce clinically relevant
bias in intervention effect estimate; for continuous outcome data,
when plausible effect size (difference in means or standardised dif-
ference in means) among missing outcomes was enough to induce
clinically relevant bias in observed effect size; and when ’as-treated’
analysis was done with a substantial departure of the intervention
received from that assigned at randomisation, with a potentially
inappropriate application of simple imputation.
We made a judgement of unclear (uncertain risk of bias) when
reporting of attrition/exclusions was insufficient to permit judg-
ment of low or high risk of bias, or when the study did not address
this outcome, and also, when the numbers randomly assigned into
intervention and control groups were not clearly reported.
Selective outcome reporting
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We assessed reporting of outcomes as being at low risk of bias when
all study outcomes declared in the Methods section were reported
in the Results. We also evaluated whether different reports of the
study were available, including protocols, and examined them to
ensure that no suggestionof selective outcome reportingwasmade.
If no description was given, we contacted study authors, and if no
response was received, we made a judgment of unclear risk of bias.
If evidence suggested selective reporting, we made a judgment of
high risk of bias for this domain.
Other potential threats to validity
We assessed other threats to validity as being at low risk of bias
if the study appeared to be free of other sources of bias, such as
being stopped early because of a data-dependent process or having
a baseline imbalance between the groups. Examples that may pose
a risk of bias could include sources of sponsorship or funding.
When the risk of bias was unclear from published information, we
attempted to contact study authors for clarification. If a response
was not forthcoming, we assessed studies as being at unclear risk
of bias for this domain.
The review authors were not blinded to the titles of journals or the
identities of study authors, as they are familiar with the field.When
the two review authors scored items differently, they attempted to
establish agreement by discussion. A third review author resolved
any persisting disagreement.
Grading the evidence
The overall quality of evidence was assessed using the GRADE ap-
proach (Guyatt 2008). The GRADE approach appraises the qual-
ity of a body of evidence based on the extent to which one can be
confident that an estimate of effect or association reflects the item
being assessed. Randomised trials start as high-quality evidence
but may be downgraded because of risk of bias (methodological
quality), indirectness of evidence, unexplained heterogeneity, im-
precision (sparse data), and publication bias. We determined the
overall quality of the evidence for each outcome after considering
each of these factors and graded our confidence in the results as
follows.
• High: further research is very unlikely to change our
confidence in the estimate of effect.
• Moderate: further research is likely to have an important
impact on confidence in the estimate of effect and may change
the estimate.
• Low: further research is very likely to have an important
impact on confidence in the estimate of effect and is likely to
change the estimate.
• Very low: any estimate of effect is very uncertain.
Measures of treatment effect
Dichotomous outcomes
We reported dichotomous outcomes (e.g. presence/absence of in-
fection) as risk ratios (RRs) with 95% confidence intervals (CIs).
For comparisons with zero events we used odds ratios (OR). For
future review updates, using control event risks from the included
trials, the number needed to treat for an additional beneficial out-
come (NNTB) and the associated 95% confidence interval will
be calculated for statistically significant dichotomous outcomes.
Also, for unwanted effects (eg, adverse events), the NNTB will
become the number needed to treat for an additional harmful out-
come (NNTH) and will be calculated in the same way.
Ordinal outcomes
When outcome data were provided on an ordinal scale (e.g. for
severity of capsular contracture: minimal, moderate, severe), we
selected a threshold based on the definition of clinically significant
contracture and converted these data into a dichotomous form.
When it was not possible to split ordinal data into dichotomous
outcomes to meet our a priori definition, we assigned a numeric
score to each category and analysed the results as continuous data.
Continuous outcomes
We calculated mean differences (MDs) of change scores when
all studies used the same measurement scale. When studies used
different scales, we calculated the standardised mean differences
(SMDs), using Hedges’ g. When necessary, we calculated effect
estimates from P values, t statistics analysis of variance (ANOVA)
tables, or other statistics (Higgins 2011b).
For this analysis, we used, according to need, either change scores
or final values without combining them.
Unit of analysis issues
We had considered that the unit of analysis needed to be the
individual participant instead of number of breasts.
For each included study, we determined whether the unit of anal-
ysis was appropriate for the unit of randomisation and the design
of each study (i.e. whether the number of observations matched
the number of units randomly assigned). In the case of inclusion
of cluster randomised trials, we planned to use the intraclass cor-
relation coefficient (ICC) to convert trials to their effective sample
size before incorporating them into the meta-analysis, according
to the recommendation in the Cochrane Handbook for Systematic
Review of Interventions (Higgins 2011c). When the ICC was not
provided, we planned to use values for ICCs available in the pub-
lished literature (Campbell 2000). We did not find any cluster
randomised trials.
Studies with multiple treatment arms
In the primary analysis, we planned to combine results across all
eligible intervention arms and to compare them with combined
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results across all eligible control arms (alternative surgical proce-
dure), making single, pair-wise comparisons. When such a strat-
egy would prevent investigation of potential sources of hetero-
geneity, we planned to analyse each surgical procedure separately
(against a common control group) but dividing the sample size for
common comparator arms proportionately across each compari-
son (Higgins 2011c). This simple approach allows the use of stan-
dard software (including RevMan 2012) and prevents inappro-
priate double-counting of individuals. We did not perform meta-
analyses because the studies used very different comparison arms.
Dealing with missing data
When data were missing, we contacted the corresponding authors
of included studies to request any unreported data. For all out-
comes in all studies, we carried out analyses as far as possible on
an intention-to-treat basis (i.e. we attempted to include all par-
ticipants randomly assigned to each group in the analyses), and
we analysed all participants in the groups to which they were allo-
cated, regardless of whether they received the allocated interven-
tion. For continuous data that weremissing, we estimated standard
deviations from other available data such as standard errors, or we
imputed them using the methods suggested in Higgins 2011c.We
made no assumptions about loss to follow-up for continuous data,
and we based analyses on those participants completing the trial. If
a discrepancy was noted between the number randomly assigned
and the number analysed in each treatment group, we calculated
and reported the percentage lost to follow-up in each group.When
it was not possible to obtain missing data, we recorded this fact on
the data collection form and reported it in the ’Risk of bias’ table;
we discussed the extent to which the missing data could alter the
results/conclusions of the review.
Assessment of heterogeneity
We considered both clinical and statistical heterogeneity. When
studies appeared similar in terms of the level of participants, in-
tervention type, and outcome type, we planned to pool the data
in a meta-analysis.
We assessed heterogeneity of effect sizes using the I2 statistic and
the Chi2 statistic (Higgins 2003).
I2 indicates the percentage of variability due to between-study (or
inter-study) variability as opposed to within-study (or intra-study)
variability.
We interpreted I2 as suggested in Higgins 2011a.
• 0% to 40%: might not be important.
• 30% to 60%: may represent moderate heterogeneity.
• 50% to 90%: may represent substantial heterogeneity.
• 75% to 100%: may represent considerable heterogeneity.
We also evaluated the confidence interval for I2.
The significance level of the Chi2 statistic was set at P < 0.10
because of the low statistical power of the test.
Assessment of reporting biases
We planned to use a funnel plot to explore reporting bias if there
were at least 10 trials for our primary outcome (Egger 1997;
Macaskill 2001). Asymmetry in the funnel plot of trial size against
treatment effect would be an indicator of this bias. We planned to
undertake a linear regression approach as described by Egger 1997
to determine funnel plot asymmetry in the presence of at least 10
trials for the outcome. In this review, we included only five trials,
did not perform meta-analysis, and so a funnel plot was not used.
Data synthesis
We planned to combine results unless diversity (surgical and/or
statistical heterogeneity) suggested that combining them was un-
reasonable. If both a continuous outcome and a dichotomous out-
comewere available for an outcome, we included only the dichoto-
mous outcome (i.e. risk ratio (RR)) in the primary analysis. We
planned to summarise capsular contracture rates using risk differ-
ences if these events were found to be rare (i.e. less than 10%). If
some studies reported an outcome as a continuous measure and
others used a dichotomous measure for the same construct, we
planned to convert results for the former from the continuous
measure to a dichotomous measure, provided that we could as-
sume a positive/negative threshold based on the definition of clin-
ically significant contracture (otherwise, we planned to carry out
two separate analyses). If outcomes were reported at different time
points that exceeded one year, we planned to pool data for each
point and to combine these with data from other trials at similar
time points. This would lead to an estimate of the onset and per-
sistence of treatment effect, at least over the time points available
for the combination of data. A decision regarding the time points
to be included in the final analysis were made by consensus after
the data had been collected.
We planned to use inverse variance methods, with the variance
including between-study variation (i.e. DerSimonian 1986 ran-
dom-effects model) to combine results across the studies because
a certain degree of heterogeneity was expected. If high statistically
heterogeneity was found we planned: 1) to redo the analysis using
the homogenous subgroup (only if a clear and compelling reason
to exclude the heterogeneous data could be found); and 2) to aban-
don statistical combination of the trials in favour of providing a
narrative review of the literature.
We planned to carry out statistical analysis using Review Man-
ager software (RevMan 2012) according to the recommendations
of theCochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011a). However, because the included studies were
composed of very heterogeneous comparisons, we did not perform
meta-analysis and provided a narrative description of the results.
The GRADE approach was used to assess the quality of the
evidence for the main outcomes. The main outcomes assessed
were capsular contracture, patient satisfaction, reintervention and
short-term complications. We created five Summary of Findings
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tables (one for each comparison) using GRADEproGDT.
Subgroup analysis and investigation of heterogeneity
We planned to do subgroup analyses to explore effect size differ-
ences, as follows.
• Trials at low risk of bias versus trials at high risk of bias
(allocation concealment versus lack of allocation concealment,
blinding versus lack of blinding).
• One- versus two-stage reconstruction.
• Radiotherapy-treated participants versus non-radiotherapy-
treated participants.
• Reconstruction after breast cancer treatment versus
reconstruction after risk-reducing procedures.
• Early breast cancer versus locally advanced breast cancer.
We planned to use the ’test for interaction’ to identify differences
between subgroups. We planned to use meta-regression (in the
presence of adequate numbers of trials) to determine the influence
of different factors on the effect estimate.
Subgroup analysis was not performed because only five studies
were included and meta-analysis was not performed.
Sensitivity analysis
We planned to conduct sensitivity analyses to determine whether
our findings were sensitive to restricting the analyses to studies
judged to be at low risk of bias for generation of allocation se-
quence and for allocation concealment. We planned to explore
the impact of including studies with high levels of missing data
in the overall assessment of treatment effect by using sensitivity
analyses. In addition, we planned to assess the sensitivity of find-
ings to any imputed data by calculating the treatment effect while
including and excluding imputed data to see whether this altered
the outcome of the analysis. We planned to investigate the effects
of dropouts and exclusions by conducting worst-case versus best-
case scenario analyses.
Sensitivity analysis was not performed because we described the
results narratively only.
R E S U L T S
Description of studies
Results of the search
The search was conducted in July 2015. After removal of dupli-
cates, we found 5241 records from the following databases: EM-
BASE (2725), MEDLINE (2082), Cochrane Central Register of
Controlled Trials (CENTRAL) (140), Cochrane Breast Cancer
Group Specialised Register (110), the World Health Organisa-
tion’s International Clinical Trials Registry Platform (WHO IC-
TRP) (75) and ClinicalTrials.gov (109).
We also performed a search across references of published studies,
and found two other reports.
After screening the titles and abstracts, we identified 10 potentially
eligible articles. We sought the full texts for the 10 articles. We
excluded four studies because they did not meet the inclusion
criteria (Benediktsson 2006; Hammerstad 1996; Macadam 2010;
Macadam 2013) (see ’Characteristics of excluded studies’ table).
Five trials with six reports contributed to this review (Benediktsson
2000; Eriksen 2012; Gahm 2010; Gylbert 1990; Thuesen 1995).
A flow diagram summarising the study selection process is shown
in Figure 1.
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Figure 1. Study flow diagram.
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Included studies
We included four trials that compared different types of im-
plants for breast reconstruction after surgery for breast cancer
(Benediktsson 2000; Eriksen2012;Gylbert 1990;Thuesen 1995),
and one trial that followed risk-reduction procedures (Gahm
2010).
The five trials included a total of 202 female participants, with a
mean of 40 women in each trial.
All trials were conducted in Northern Europe (Sweden and Den-
mark).
Summaries of the five trials are givenbelow.All the studies reported
submuscular placement of the implant following the mastectomy
except for Benediktsson 2000 which used subcutaneous implant
positioning. For further details, see the Characteristics of included
studies tables.
Benediktsson 2000 included 41 women (mean age 55 years) hav-
ingmodified radical mastectomies (MRM) with immediate recon-
struction (IR) and compared subcutaneous positioning of textured
PVP-hydrogel-filled implants versus subcutaneous positioning of
textured saline-filled implants. Follow-up assessment for the pri-
mary outcome (capsular contracture) was at 12 months.
Eriksen 2012 randomised 70 women, 40 of whom were included
in this analysis (mean age 50 years). This trial compared MRM
with IR using submuscular positioning of textured round variable
volume Becker implants versus MRM and two-stage reconstruc-
tion with submuscular positioning of textured crescent-shaped ex-
panders, later replaced by textured silicone-filled fixed volume im-
plants.Mean follow-up assessment for the primary outcome (qual-
ity of life) was three and a half years.
Gylbert 1990 included 65 women (mean age 49 years) and com-
pared MRM with IR using submuscular positioning of smooth
silicone-filled implants versus MRM with IR using submuscular
positioning of smooth saline-filled implants. Mean follow-up as-
sessment for the primary outcome (capsular contracture) was six
years.
Thuesen 1995 included 20 women (mean age 50 years) and com-
pared MRM with IR using submuscular positioning of textured
silicone-filled implants versus MRM with IR using submuscular
positioning of smooth silicone-filled implants. Mean follow-up
assessment for the primary outcome (capsular contracture) was
three years.
Gahm 2010 included 36 women (mean age 38 years) and com-
pared bilateral prophylactic mastectomies with IR using sub-mus-
cular positioning of textured anatomically-shaped permanent ex-
pander implants (saline-filled) versus bilateral prophylactic mas-
tectomies with IR using sub-muscular positioning of textured
round permanent expander implants (saline-filled). Mean follow-
up assessment for the primary outcome was 30 months.
Excluded studies
We excluded four studies because they were not RCTs (
Benediktsson 2006; Hammerstad 1996; Macadam 2010;
Macadam 2013). See Characteristics of excluded studies.
Risk of bias in included studies
Summaries of our risk of bias assessment of the included studies
are presented in Figure 2.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Allocation
None of the trials gave details about their method of random
sequence generation and allocation concealment; so we considered
them to be at unclear risk of bias. Only Eriksen 2012 reported a
valid allocation concealment strategy.
Blinding
Due to the surgical nature of the intervention, the operators could
not be blinded to the type of implant used.
None of the studies reported information about blinding of the
participants.
Two studies did not report any information about the blinding
of outcome assessors and were judged to be at unclear risk of
bias (Benediktsson 2000; Thuesen 1995). One study reported
that there was an independent outcome assessor who was unaware
of the implant used (Gylbert 1990), but the investigation could
not be labelled as strictly blinded, as experienced surgeons could
easily detect the difference between a saline- and a silicone-filled
implant, sowe rated it as being at high risk of bias. Gahm 2010 and
Eriksen 2012 used a blinded expert panel of assessors to evaluate
standardised photographs of each breast and we rated them as
being at low risk of bias for this domain.
Incomplete outcome data
None of the trials reported their method of analysis (intention-
to-treat or by protocol). Considering the significant percentage
of losses to follow-up and women excluded from the analysis for
various reasons, we judged that three studies were at high risk of
bias (Eriksen 2012; Gahm 2010; Gylbert 1990). We judged two
studies to be at low risk of bias: Benediktsson 2000 because women
excluded from the analysis were few, the reasons were reported
and were balanced between groups; and Thuesen 1995 because
women were all included in the follow-up.
Selective reporting
Published trial registration informationor protocolswere not avail-
able for any of the five trials. However, all the outcomes that were
listed in the Methods sections were reported in the Results sec-
tions, so we judged all the trials to be at low risk of bias for this
domain.
Other potential sources of bias
Two studies reported that they hadno competing interests (Eriksen
2012; Gahm 2010); the other studies did not report informa-
tion of this kind. The source of financial support was reported
in three studies (Benediktsson 2000; Eriksen 2012; Gahm 2010),
and was provided by research foundations with no involvement in
the study. The other studies did not report any information. Base-
line characteristics considered in the included trials were mostly
balanced between treatment groups but the number of covariates
explored was limited. We judged all the studies to be at unclear
risk of bias for this domain.
Effects of interventions
See: Summary of findings for the main comparison Textured
versus smooth implants for reconstructive breast surgery;
Summary offindings 2Silicone-filled versus saline-filled implants
for reconstructive breast surgery; Summary of findings 3 PVP-
hydrogel-filled versus saline-filled implants for reconstructive
breast surgery; Summary of findings 4 Anatomical versus round
implants for reconstructive breast surgery; Summary of findings
5 Variable- versus fixed-volume implants for reconstructive breast
surgery
Capsular contracturerate and severity
Four studies considered capsular contracture (Benediktsson 2000;
Gahm2010;Gylbert 1990;Thuesen1995).When theBaker grade
classes were reported, we dichotomised the outcome and consid-
ered Baker classes 3 and 4 as indicating severe contracture, and
Baker classes 1 and 2 as acceptable.
Implant envelope surfaces: textured versus smooth implants
In Thuesen 1995 no significant difference in capsular contracture
was found between textured versus smooth implants groups (RR
0.82, 95% CI 0.14 to 4.71; 20 participants; Analysis 1.1). Baker
class 3 or 4 was found in two out of 11 women in the textured
implants group versus two out of nine women in the smooth
implants group.
Implant filler material: silicone-filled versus saline-filled
implants
Gylbert 1990 reported significantly more severe capsular contrac-
ture with a RR of 3.25 (95% CI 1.24 to 8.51; 60 participants;
Analysis 1.2), in women with silicone-filled compared to saline-
filled implants. Severe capsular contracture (class 3 or 4) was found
in 17/34 (50%) of women who had silicone-filled breast implants,
compared with 4/26 (16%) of women who had saline-filled im-
plants.
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Implant filler material: PVP-hydrogel-filled implants versus
saline-filled implants
In Benediktsson 2000 no significant difference in severe capsular
contracture rate was found between women with PVP-hydrogel-
filled implants and women with saline-filled implants (RR 3.50,
95% CI 0.83 to 14.83; 40 participants; Analysis 1.3). Seven out
of 20 women who had PVP-hydrogel-filled implants reported a
Baker class 3 or 4 compared with two out of 20 women who
had saline-filled implants. No significant difference in applanation
tonometry was observed between groups.
Implant shape: anatomical versus round implants
Gahm2010 reported a non significant difference in severe capsular
contracture (Baker class not specified) for women with anatomical
versus round implants (RR 2.0, 95% CI 0.20 to 20.15; 36 par-
ticipants; Analysis 1.4). Two out of 18 women developed severe
capsular contracture in the anatomical implants group compared
to one out of 18 women in the round implants group.
Implant volume: variable- versus fixed-volume implants
No study examined this outcome for this comparison.
Brands: different implant manufacturing companies
No study made this comparison.
Implant generation: fifth versus previous generations of
silicone implants
No study made this comparison.
Participant-reported outcomes: postoperative quality
of life or satisfaction level
Three studies considered participant-reported outcomes (Eriksen
2012; Gahm 2010; Gylbert 1990).
Implant envelope surfaces: textured versus smooth implants
No study examined this outcome for this comparison.
Implant filler material: silicone-filled versus saline-filled
implants
Gylbert 1990 reported no significant differences concerning ten-
derness of the reconstruction area, palpable wrinkling and sound
emanating from the implants in 58 women.Women with silicone-
filled implants were significantly less satisfied with the consistency
of the reconstructed breast when compared to women with saline-
filled implants (RR 0.60, 95% CI 0.41 to 0.88; 58 participants;
Analysis 2.1). A slightly higher number of women in the saline
group reported a decrease in size during the five years of follow-
up compared to women in the silicone-filled implant group (RR
0.55, 95% CI 0.24 to 1.27; 58 participants; Analysis 2.2).
Implant filler material: PVP-hydrogel-filled versus saline-
filled implants
No study examined this outcome for this comparison.
Implant shape: anatomical versus round implants
Gahm 2010 reported patients’ satisfaction level data in 26 out of
36 women (12 in the anatomical implant group and 14 in the
round implant group). Six women from the anatomical group and
four women from the round group had their implant exchanged
and these women were excluded from the aesthetic evaluation.
Satisfaction was expressed using a scale ranging from 1 (“not at
all [satisfied]”) to 7 (“absolutely [satisfied]”), with a score of 4
considered “acceptable”. The median overall aesthetic result score
was 6 for both the anatomical and round implant group.
Implant volume: variable- versus fixed-volume implants
Eriksen 2012 reported a higher level of patient satisfaction (rated
from 1 to 6, with 1 being very bad and 6 being very good) in
the two-stage fixed-volume implants group compared with the
one-stage variable-volume implants group; overall aesthetic result
(MD -1.10, 95%CI -1.59 to -0.61; 40 participants; Analysis 2.3).
Eighty per cent of the women in the two-stage fixed-volume im-
plants group said that the results corresponded “very much” to
their expectations versus 20% in the one-stage variable-volume
implants group (RR 0.25, 95% CI 0.10 to 0.62; 40 participants;
Analysis 2.4). All women would definitely recommend their op-
eration to another woman in the two-stage fixed-volume implants
group, compared to 75% in the one-stage variable-volume im-
plants group (RR 0.76, 95% CI 0.58 to 0.98, 40 participants;
Analysis 2.5). No significant differences in quality of life were
found between the two groups (raw data were not reported).
Brands: different implant manufacturing companies
No study dealt with this comparison.
Implant generation: fifth versus previous generations
No study dealt with this comparison.
Implant rupture and filler material migration rates
No studies reported data on this outcome.
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Short-term complication rates (implant infection,
seroma, haematoma, implant extrusion, and implant
malpositioning)
Two studies reported data on this outcome (Benediktsson 2000;
Gahm 2010).
Implant envelope surfaces: textured versus smooth implants
No study examined this outcome for this comparison.
Implant filler material: silicone-filled versus saline-filled
implants
No study examined this outcome for this comparison.
Implant filler material: PVP-hydrogel-filled implants versus
saline-filled implants
Benediktsson 2000 reported no significant difference in implant
infection rates when comparing PVP-hydrogel-filled implants to
saline-filled implants (RR 2.10, 95% CI 0.21 to 21.39; 41 partic-
ipants; Analysis 3.1).
Implant shape: anatomical versus round implants
Gahm 2010 reported no significant difference in short-term com-
plications when comparing anatomical versus round implants (RR
2.00, 95% CI 0.42 to 9.58; 36 participants; Analysis 3.2).
Implant volume: variable- versus fixed-volume implants
No study examined this outcome for this comparison.
Brands: different implant manufacturing companies
No study dealt with this comparison.
Implant generation: fifth versus previous generations
No study dealt with this comparison.
Reintervention and long-term complication rates:
late seroma double-capsule formation and chronic
pain
Four studies reported data about reinterventions required because
of various complications or insufficiently aesthetic results (Eriksen
2012; Gahm 2010; Gylbert 1990; Thuesen 1995).
Implant envelope surfaces: textured versus smooth implants
Thuesen 1995 reported that two women in each group had to be
reoperated on because of Baker 3 capsular contracture (RR 0.82,
95% CI 0.14 to 4.71; 20 participants; Analysis 4.1).
Implant filler material: silicone-filled versus saline-filled
implants
Gylbert 1990 reported that no silicone-filled implants were re-
moved for any reason while six women had their saline-filled im-
plants removed because of deflation (OR 0.08, 95% CI 0.01 to
0.43; 60 participants; Analysis 4.2).
Implant filler material: PVP-hydrogel-filled implants versus
saline-filled implants
No study examined these outcomes for this comparison.
Implant shape: anatomical versus round implants
Gahm 2010 reported no significant difference in reintervention
rates when comparing anatomically-shaped versus round implants
(RR 1.50, 95% CI 0.51 to 4.43; 36 participants; Analysis 4.3).
Implant volume: variable- versus fixed-volume implants
Eriksen 2012 reported significantly fewer reinterventions in
women undergoing two-stage reconstructions with fixed-volume
implants compared to one-stage variable-volume reconstructions
(RR 7.00, 95% CI 1.82 to 26.89; 40 participants; Analysis 4.4).
Brands: different implant manufacturing companies
No study dealt with this comparison.
Implant generation: fifth versus previous generations
No study dealt with this comparison.
Cosmetic outcomes not reported by participants
Two studies reported data about cosmetic outcomes evaluated by
an independent panel through digital standardised photographs
(Eriksen 2012; Gahm 2010).
Implant envelope surfaces: textured versus smooth implants
No study examined this outcome for this comparison.
Implant filler material: silicone-filled versus saline-filled
implants
TNo study examined this outcome for this comparison.
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Implant filler material: PVP-hydrogel-filled implants versus
saline-filled implants
No study examined this outcome for this comparison.
Implant shape: anatomical versus round implants
In Gahm 2010, the median outcome scores for each category
did not show any significant difference between the two implant
groups: the median overall aesthetic result was 4.88 and 4.50 for
anatomically-shaped and round implants, respectively (analysis
not performed). Agreement between the outcome assessors was
moderate (mean kappa values between 0.36 and 0.57).
Implant volume: variable- versus fixed-volume implants
In Eriksen 2012, expert panels awarded the highest scores for over-
all aesthetic result to the two-stage fixed-volume implants group
compared to the one-stage variable-volume implants group (ex-
pert panel: MD -0.70, 95% CI -1.17 to -0.23; 40 participants;
Analysis 5.1), but this was not the case for the lay panel (MD -
0.30, 95% CI -0.84 to 0.24; 40 participants; Analysis 5.2).
Brands: different implant manufacturing companies
No study dealt with this comparison.
Implant generation: fifth versus previous generations
No study dealt with this comparison.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Silicone- filled versus saline- filled implants for reconstructive breast surgery
Patient or population: women having reconstruct ive breast surgery
Settings: cancer centre
Intervention: silicone-f illed implants
Comparison: saline-f illed implants
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Saline- filled Silicone- filled
Capsular contracture
Number of women with
capsular contracture
Follow-up: mean 6
years
Study population RR 3.25
(1.24 to 8.51)
60
(1 study)
⊕©©©
very low1,2
154 per 1000 500 per 1000
(191 to 1000)
M oderate
154 per 1000 500 per 1000
(191 to 1000)
Patient satisfaction for
consistency
Number of women sat-
isf ied
Follow-up: mean 6
years
Study population RR 0.60
(0.41 to 0.88)
58
(1 study)
⊕©©©
very low1,2
833 per 1000 500 per 1000
(342 to 733)
M oderate
833 per 1000 500 per 1000
(342 to 733)
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Reintervention
Number of women with
reintervent ion
Follow-up: mean 6
years
Study population OR 0.08
(0.01 to 0.43)
60
(1 study)
⊕©©©
very low1,2
231 per 1000 23 per 1000
(3 to 114)
M oderate
231 per 1000 23 per 1000
(3 to 114)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RR: risk rat io; OR: odds rat io
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1We downgraded twice based on unclear risk of select ion and performance bias, high risk of attrit ion and detect ion bias.
2We downgraded once on the basis that there was only one study with 65 part icipants. Dif ferent numbers of part icipants have
been analysed for each outcome.
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PVP-hydrogel- filled versus saline- filled implants for reconstructive breast surgery
Patient or population: women having reconstruct ive breast surgery
Settings: cancer centre
Intervention: PVP-hydrogel-f il led implants
Comparison: saline-f illed implants
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Saline- filled implants PVP-hydrogel- filled
implants
Capsular contracture
Number of women with
capsular contracture
Follow-up: mean 12
months
Study population RR 3.50
(0.83 to 14.83)
40
(1 study)
⊕©©©
very low1,2
100 per 1000 350 per 1000
(83 to 1000)
M oderate
100 per 1000 350 per 1000
(83 to 1000)
Short- term complica-
tions
Number of women with
at least one short-term
complicat ion
Follow-up: mean 12
months
Study population RR 2.10 (0.21 to 21.39) 41
(1 study)
⊕©©©
very low1,2
48 per 1000 100 per 1000
(10 to 1000)
M oderate
48 per 1000 100 per 1000
(10 to 1000)
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* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RR: risk rat io
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1We downgraded twice based on unclear risk of select ion, performance and detect ion bias.
2We downgraded once on the basis that there was only one study with 41 women.
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Anatomical versus round implants for reconstructive breast surgery
Patient or population: women having reconstruct ive breast surgery
Settings: cancer centre
Intervention: anatomical implants
Comparison: round implants
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Round implants Anatomical implants
Capsular contracture
Number of women with
capsular contracture
Follow-up: mean 30
months
Study population RR 2.00
(0.2 to 20.15)
36
(1 study)
⊕©©©
very low1,2
56 per 1000 111 per 1000
(11 to 1000)
M oderate
56 per 1000 111 per 1000
(11 to 1000)
Short- term complica-
tions
Number of women with
at least one short-term
complicat ion
Follow-up: mean 30
months
Study population RR 2.00
(0.42 to 9.58)
36
(1 study)
⊕©©©
very low1,2
111 per 1000 222 per 1000
(47 to 1000)
M oderate
111 per 1000 222 per 1000
(47 to 1000)
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Reintervention
Number of women with
reintervent ion
Follow-up: mean 30
months
Study population RR 1.50
(0.51 to 4.43)
36
(1 study)
⊕©©©
very low1,2
222 per 1000 333 per 1000
(113 to 984)
M oderate
222 per 1000 333 per 1000
(113 to 984)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RR: risk rat io
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1We downgraded twice based on unclear risk of select ion and performance bias and high risk of attrit ion bias.
2We downgraded once on the basis that there was only one study with 36 part icipants.
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Variable- versus fixed-volume implants for reconstructive breast surgery
Patient or population: women having reconstruct ive breast surgery
Settings: cancer centres
Intervention: one-stage variable-volume implants
Control: two-stage f ixed-volume implants
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Two-stage fixed vol-
ume implants
One-stage variable vol-
ume implants
Patient satisfaction:
correspondence to ex-
pectations
Number of women
report ing correspon-
dence with expectat ion
Follow-up: mean 3.5
years
Study population RR 0.25
(0.10 to 0.62)
40
(1 study)
⊕©©©
very low1,2
800 per 1000 200 per 1000
(80 to 496)
M oderate
800 per 1000 200 per 1000
(80 to 496)
Patient satisfaction:
aesthetic results
Rating scale f rom 1 to
6 (1 being very bad and
6 being very good)
Follow-up: mean 3.5
years
The mean patient sat-
isfact ion, aesthet ic re-
sults in the control
group was
4.2 score
The mean patient sat-
isfact ion, aesthet ic re-
sults in the intervent ion
groups was
1.1 lower
(1.59 lower to 0.61)
40
(1 study)
⊕©©©
very low1,2
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Reintervention
Number of women with
re intervent ion
Follow-up: mean 3.5
years
Study population RR 7.0
(1.82 to 26.89)
40
(1 study)
⊕©©©
very low1,2
100 per 1000 700 per 1000
(182 to 1000)
M oderate
100 per 1000 700 per 1000
(182 to 1000)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk rat io;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1We downgraded twice based on unclear risk of select ion and performance bias and high risk of attrit ion bias.
2We downgraded once on the basis that there was only one study with 40 part icipants.
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D I S C U S S I O N
Summary of main results
The aim of this review was to assess the effects of different types
of breast implants on capsular contracture, surgical short- and
long-term complications, cosmetic outcomes, postoperative satis-
faction level and quality of life in women who have undergone
reconstructive breast surgery after mastectomy. We included five
heterogeneous randomised controlled trials, involving a total of
202 women who underwent mastectomy for breast cancer (four
studies) or as a risk-reducing procedure (one study). Trials re-
ported data about different comparisons: texturised silicone ver-
sus smooth silicone implants, silicone versus saline-filled implants,
poly(N-vinyl-2-pyrrolidone) (PVP)-hydrogel- versus saline-filled
implants, anatomically versus round implants (in the risk-reducing
setting), and one-stage variable-volume implants versus two-stage
fixed-volume implants. The majority of studies explored submus-
cular placements of the implants instead of subcutaneous place-
ments. Only two of these comparisons showed a significant dif-
ference for some of the outcomes considered. The comparison
of silicone- versus saline-filled implants favoured saline-filled im-
plants for some outcomes, specifically, fewer severe capsular con-
tractures, and ahigher number ofwomen satisfiedwith their recon-
structed breast, however, there was a lower reintervention rate in
the silicone-filled group. In addition, the comparison of one-stage
variable-volume implants versus two-stage fixed-volume implants
favoured the fixed-volume implants with significantly higher sat-
isfaction levels in women and significantly lower reintervention
rates. The better results in terms of satisfaction level and reinter-
vention rates in the fixed-volume group could be attributable to
the different surgical approach (a two-stage surgical process instead
of a one-stage process). The small number of women included in
each study did not allow us to draw any definitive conclusions
about all the considered outcomes.
Overall completeness and applicability of
evidence
Despite breast cancer surgery being one of the most commonly
performed procedures in surgical oncology, the number of women
involved in randomised controlled trials investigating implant
breast reconstruction is extremely low. This ’under-randomisation’
is common in surgical research, and is caused by the challenges
of conducting surgical trials, and also by surgeons’ rejection and
limited understanding of trial methodology (Potter 2014).
Outcomes reported in each study were often reported using scales
that were not standardised. The patient-reported outcome mea-
sures (PROMs) were often reported according to study-specific,
non-validated scales. The recent definition of a core outcome set
in reconstructive breast surgery will allow researchers to choose
appropriate and standardised outcomes when conducting clinical
trials, thus eliminating reporting bias and facilitating data synthe-
sis (Potter 2015).
Only two studies included women who underwent postmastec-
tomy radiotherapy (PMRT). The effect of PMRT on reconstruc-
tive surgical outcomes cannot be predicted, and no conclusions
can be drawn for women who have had radiotherapy.
Even though only one trial included women undergoing breast
reconstruction following risk-reducingmastectomy (Gahm 2010),
we can assume that the overall clinical results could be applied to
this group of women as well, given that the surgical technique is
the same in women with operable breast cancer. However, other
outcomes such as PROMs might differ. Women undergoing risk-
reducing mastectomy are significantly different in terms of their
psychological background and we suppose that the PROMs could
not be extended fromwomen with operable cancer to women who
undergo a risk-reducing mastectomy.
Although all of the included trials have been conducted in a well-
defined area of Northern Europe, we do not have major concerns
related to the generalisability of the clinical outcome results. The
baseline characteristics of the women seem to represent the general
breast cancer population well. Concerns exist around the repre-
sentativeness of the aesthetic outcomes, meaning that there might
be plausible differences in aesthetic appreciation of beauty across
different cultural settings.
Quality of the evidence
All of the included trials had methodological shortcomings that
placed them at high or unclear risk of bias for most risk of bias
domains.
Based on the high risk of bias of the included trials and the impre-
cision of the results, we conclude that the evidence for all primary
outcomes is of very low quality, which means that we are very
uncertain about the reported results.
Moreover the quality of the reporting was very low: none of the
studies followed the CONSORT2010 guidelines, which often led
to difficulty when interpreting the results. Although we are not
surprised that our surgical colleagues did not follow the reporting
guidelines strictly (Ahmed 2013), we were disappointed by the
number of inaccuracies and incompleteness of data.
Potential biases in the review process
We conducted extensive searches and were careful and systematic
in our screening processes, but it is possible that we may have
failed to identify studies, especially those that are unpublished.We
were unsuccessful in our attempts to obtain further information
and data on the included trials from the trial authors. The poor
reporting of included trials may have affected our data extraction
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process, and frequently led to an assessment of unclear for the risk
of bias.
Agreements and disagreements with other
studies or reviews
To our knowledge there have been no previous systematic reviews
directly comparingdifferent types of implants in breast reconstruc-
tive surgery. Other systematic reviews have compared the effects
of different types of implants on capsular contracture in breast
augmentation (Wong 2006), suggesting that textured implants re-
duce the risks of early capsular contracture compared with smooth
implants.
The assessment of cosmetic outcomes and PROMs after breast re-
constructive surgery have been investigated in systematic reviews
and they have highlighted the lack of consistency andmethodolog-
ical rigour in outcome reporting (Chen 2010; Lee 2009; Potter
2011a; Potter 2011b ).
Evidence about patient satisfaction and health-related quality of
life following breast reconstruction (using the BREAST-Q ques-
tionnaire) derived from small observational studies that compared
different types of implants showed higher satisfaction with sili-
cone-filled implants than with saline-filled implants (Macadam
2010). Further observational research showed no differences in
terms of satisfaction with outcomes when anatomical silicone-
filled implants were compared with round implants (Macadam
2013).
The largest amount of evidence about breast implants comes from
the US Food and Drug Administration (FDA) postapproval stud-
ies that are referred to as core studies. These prospective obser-
vational studies investigated complication profiles for the FDA-
approved implant manufacturers, which the FDA required after
the temporary moratorium on silicone breast implants in the USA
between 1992 and 2006. These studies now provide results with
10 year follow-up (FDA). The Allergan core study (Maxwell 2012)
and the Mentor core study (Hammond 2012) reported 10.7%
and 10.1% capsular contracture rates, respectively, after primary
breast reconstruction at six years of follow-up. Most of the studies
included in our review reported significantly higher capsular con-
tracture rates when compared with data derived from these core
studies, which was probably due to the use of older generation
implants and obsolete surgical techniques in the included RCTs.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The available evidence is too weak to draw conclusions about
which is the best implant to use in breast reconstructive surgery.
The current trend in breast reconstructive surgery is driven by
studies with a low level of evidence. This issue should be discussed
when informing women about the benefits, risks and complica-
tions of surgery for breast reconstruction. Recommendations re-
garding options for different implant-based breast reconstruction
seem to be based on expert opinions or anecdotic experience at
best. The lack of high-quality evidence and the underlying uncer-
tainty about different types of approaches might reduce the out-
comes expected by women from this type of treatment and reduce
their willingness to resort to surgery.
Implications for research
Considering the high incidence of breast cancer, its strong social
implications and the low quality of evidence available on breast
reconstructive surgery, new high-quality randomised controlled
trials that include a higher number of women and that compare
different types of implants appear to be needed deeply. Women
with breast cancer are cared for and monitored in specialist breast
units, often connected to national or international networks (e.g.
European Society of Breast Cancer Specialists - EUSOMA) to en-
sure quality of service. Parts of these breast cancer centres could
easily be connected in a research network to take on this surgical
research challenge. From this perspective, a large multicentre clin-
ical trial is possible.
A C K N OW L E D G E M E N T S
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Benediktsson 2000
Methods Randomised controlled trial
Participants 41 women (mean age 55 years) undergoing modified radical mastectomy and immediate
one-stage reconstruction for breast cancer
Interventions 20 women undergoing subcutaneous positioning of textured PVP-hydrogel-filled im-
plant versus 21 women undergoing subcutaneous positioning of textured saline-filled
implant
Outcomes Capsular contracture rate and severity at 1 year (Baker’s classification (Palmer 1992)
considering significant capsular contracture as Baker ≥ 2 or differences in applanation
tonometry operative/postoperative ratio of ≤ 0.75); data on 40 patients
Short-term complications: infection rate; data on 41 patients
Notes Follow-up: 12 months
Source of support: this research was supported by the Ryan Hill Research Foundation
and by the Serafimer Hospital Foundation
Competing interests: information not reported
41women randomised; 40women analysed for capsular contracture; 41women analysed
for short-term complications
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not reported
Allocation concealment (selection bias) Unclear risk Method not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Information not reported
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Expert panel (3 surgeons and1nurse). Information about
blinding of the panel not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Two of the Misti Gold implants and one of the
saline-filled type were removed because of infection.”;
few dropouts, balanced between groups
Selective reporting (reporting bias) Low risk No protocol available, but outcomes listed in the Meth-
ods section were reported in the Results
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Benediktsson 2000 (Continued)
Other bias Unclear risk Insufficient baseline characteristics; competing interests
not reported
Eriksen 2012
Methods Randomised controlled trial
Participants 70 women (mean age 50 years) undergoing modified radical mastectomy and immediate
one- or two-stage reconstruction for breast cancer
Note: a total of 40 participants were included in the analysis
Interventions 35 one-stage submuscular positioning of textured round permanent expander Becker
implant versus 35 two-stage submuscular positioning of textured crescent-shaped ex-
panders, later replaced by textured silicone-filled implants
Note: 20 participants from each group were included in the analysis
Outcomes Participant-reported outcomes: quality of life (QoL; evaluated preoperatively and post-
operatively with SF-36) and satisfaction level using a study-specific questionnaire (scale
ranging from 1, ’very bad’ to 6, ’very good’) about aesthetic outcomes (shape, size, scars,
nipple-areola complex, symmetry and overall aesthetic results), expectations reached
(scale from 1 to 6, being 1-2 ’not at all’, 3-4 ’some’ and 5-6 ’very much’) and recom-
mendations to other women (scale from 1 to 6, being 1-2 ’never’, 3-4 ’probably’, 5-6
’definitely’);
Reintervention rate;
Cosmetic outcome not reported by participants: two panels composed of experts (6 plas-
tic surgeons) and lay people (6 people with no connection to the medical profession)
scored the categories (upper pole fullness, projection, ptosis, inframammary fold, sym-
metry, shape, volume, scars, nipple-areola complex and overall aesthetic results) from
unidentified photographs using a scale from 1 (’very bad’) to 6 (’very good’)
Notes Follow-up: median 3.5 years (range 1.5 to 5 years)
Financial support: this study was supported by grants from the Swedish Breast Cancer
Association
Competing interests: “The authors have no financial interest to declare in relation to the
content of this article.”
70 women randomised; 40 women analysed for each outcome
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not reported
Allocation concealment (selection bias) Low risk Quote: “Presealed envelopes ordered from the state phar-
macy company”
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Eriksen 2012 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Information not reported
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Two panels, 6 experts (plastic surgeons) and 6 lay people,
evaluated standard photographic documentation
Incomplete outcome data (attrition bias)
All outcomes
High risk 43% dropout after randomisation, balanced between
groups and no intention-to-treat analyses
Selective reporting (reporting bias) Low risk No protocol available, but outcomes listed in the Meth-
ods section were reported in the Rsesults
Other bias Unclear risk Insufficient baseline characteristics;
Gahm 2010
Methods Randomised controlled trial
Participants 36 women (mean age 38 years) undergoing bilateral risk-reducing mastectomy and
immediate reconstruction
Interventions 18 women undergoing bilateral one-stage submuscular positioning of textured anatom-
ically-shaped permanent expander implants versus 18 women undergoing bilateral sub-
muscular positioning of textured round permanent expander implants
Outcomes Capsular contracture rate and severity at 30 months (Baker classification)
Participant-reported outcomes: satisfaction level (study-specific questionnaire addressing
aesthetic and lifestyle issues with a scale ranging from 1 (’not at all [satisfied]’) to 7
(’absolutely [satisfied]’));
Short-term complications: infection, haematoma, implant malpositioning;
Long-term complications: pain;
Reintervention rate;
Cosmetic outcome not reported by participants: a blinded expert panel (3 plastic sur-
geons not involved in the surgical procedure and a specially educated nurse) evaluated 4
standardised digital photographs of each breast. The assessed categories for each single
breast were: appearance of the upper pole, projection, inframammary fold, natural look,
implant edges and shape. Appearance of cleavage, symmetry in shape, scar tissue and
overall aesthetic results were assessed for both breasts. Each category was scored using a
scale ranging from 1 (’not at all [satisfied]’) to 7 (’absolutely [satisfied]’) and a mean was
calculated as a final score for each category
Notes Follow-up: average 30 months (range 24 to 49 months)
Financial support: this research was supported in part by grants from the Capio Research
Foundation. The Capio Research Foundation had no involvement in the study design,
materials and methods, or manuscript process
Competing interests: none of the authors of this article had a conflict of interest to declare
36Different types of implants for reconstructive breast surgery (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gahm 2010 (Continued)
36 women randomised; 36 women analysed for each outcome
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not reported
Allocation concealment (selection bias) Unclear risk Method not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Information not reported
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded expert panel (3 plastic surgeons not involved in
the surgical procedures and a nurse specially educated in
patient undergoing breast reconstruction) that evaluated
4 standardised digital photographs of each breast
Incomplete outcome data (attrition bias)
All outcomes
High risk Significant exclusion from analyses (10 participants ex-
cluded from the aesthetic evaluation because they re-
ceived a reimplant)
Selective reporting (reporting bias) Low risk No protocol available, but outcomes listed in the Meth-
ods section were reported in the Results
Other bias Unclear risk Insufficient baseline characteristics provided. Informa-
tion about competing interests not reported
Gylbert 1990
Methods Randomised controlled trial
Participants 65 women (mean age 49 years) undergoing modified radical mastectomy and immediate
reconstruction for breast cancer
Interventions 32 women had submuscular positioning of smooth silicone-filled implants versus 33
women who had submuscular positioning of smooth saline-filled implants
Outcomes Capsular contracture rate and severity at 6 years of follow-up according to the breast
augmentation classification (BAC) which is a modification of Baker’s classification (
Gylbert 1989); data on 60 patients;
Participant-reported outcomes: satisfaction level (study-specific questionnaire about con-
sistency of the breast, tenderness of the reconstruction areas, wrinkles on the prosthesis,
sound from the prosthesis, changes in size of reconstructed breast); data on 58 patients;
Long-term complications: implant deflation; data on 58 patients;
Reintervention rate; data on 60 patients.
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Gylbert 1990 (Continued)
Notes Follow-up: mean 6 years (range: 5.5 to 7.5 years)
Financial support: information not reported
Competing interests: information not reported
65 women randomised; 60 women analysed for capsular contracture and reintervention
rate; 58women analysed for participant-reported outcomes and long-term complications
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not reported
Allocation concealment (selection bias) Unclear risk Method not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Information not reported
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Independent plastic surgeon unaware of the type of pros-
thesis used for reconstruction, but not strictly blinded
because in 80% of patients the doctors could tell what
type of implant had been employed
Incomplete outcome data (attrition bias)
All outcomes
High risk 28% drop out rate, reasons reported, unbalanced across
groups
Selective reporting (reporting bias) Low risk No protocol available, but outcomes listed in the Meth-
ods section were reported in the Results
Other bias Unclear risk Insufficient baseline characteristics. No information re-
ported about competing interests or funding
Thuesen 1995
Methods Randomised controlled trial
Participants 20women (mean age 50 years) undergoingmodified radical mastectomy for breast cancer
and immediate reconstruction
Interventions 11 two-stage reconstructions with submuscular positioning of expander later replaced
by textured silicone-filled implants versus 9 two-stage reconstructions with submuscular
positioning of expander later replaced by smooth silicone-filled implants
Outcomes Capsular contracture rate and severity at a median follow-up of 3 years (Baker classifi-
cation);
Participant-reported outcomes: satisfaction level (data not extractable);
Reintervention rate
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Thuesen 1995 (Continued)
Notes Follow-up: mean 3 years (range 1 to 4 years)
Financial support: information not reported
Competing interests: information not reported
20 women randomised; 20 women analysed for each outcome
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not reported
Allocation concealment (selection bias) Unclear risk Method not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Information not reported
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Information not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss at follow-up
Selective reporting (reporting bias) Low risk No protocol available, but outcomes listed in the Meth-
ods section were reported in the Results
Other bias Unclear risk Insufficient baseline characteristics. No information re-
ported about competing interests or funding
BAC: breast augmentation classification
PVP-hydrogel: poly(N-vinyl-2-pyrrolidone) hydrogel
QoL: quality of life
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Benediktsson 2006 Not an RCT study design
Hammerstad 1996 Not an RCT study design
Macadam 2010 Not an RCT study design
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(Continued)
Macadam 2013 Not an RCT study design
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D A T A A N D A N A L Y S E S
Comparison 1. Capsular contracture
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Textured vs smooth implants 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Silicone-filled vs saline-filled
implants
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3 PVP-hydrogel-filled vs
saline-filled implants
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Anatomical vs round implants 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 2. Patient satisfaction
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Silicone-filled vs saline-filled
implants: patient satisfaction
for consistency
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Silicone-filled vs saline-filled
implants: size decrease
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Variable- vs fixed-volume
implants: patient satisfaction,
aesthetic results
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4 Variable- vs fixed-volume
implants: patient satisfaction,
correspondence to expectations
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5 Variable- vs fixed-volume
implants: patient satisfaction,
recommending to others
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 3. Short-term complications
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 PVP-hydrogel-filled vs
saline-filled implants
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Anatomical vs round implants 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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Comparison 4. Reintervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Textured vs smooth implants 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Silicone-filled vs saline-filled
implants
1 Peto Odds Ratio (Peto, Fixed, 95% CI) Totals not selected
3 Anatomical vs round implants 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Variable-volume vs fixed-volume
implants
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 5. Cosmetic outcomes not reported by participants
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Variable- vs fixed-volume
implants: cosmetic outcomes
according to expert panel
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2 Variable- vs fixed-volume
implants: cosmetic outcomes
according to lay panel
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Analysis 1.1. Comparison 1 Capsular contracture, Outcome 1 Textured vs smooth implants.
Review: Different types of implants for reconstructive breast surgery
Comparison: 1 Capsular contracture
Outcome: 1 Textured vs smooth implants
Study or subgroup Textured implants Smooth implants Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thuesen 1995 2/11 2/9 0.82 [ 0.14, 4.71 ]
0.002 0.1 1 10 500
Favours textured Favours smooth
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Analysis 1.2. Comparison 1 Capsular contracture, Outcome 2 Silicone-filled vs saline-filled implants.
Review: Different types of implants for reconstructive breast surgery
Comparison: 1 Capsular contracture
Outcome: 2 Silicone-filled vs saline-filled implants
Study or subgroup Silicone-filled Saline-filled Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gylbert 1990 17/34 4/26 3.25 [ 1.24, 8.51 ]
0.01 0.1 1 10 100
Favours silicone Favours saline
Analysis 1.3. Comparison 1 Capsular contracture, Outcome 3 PVP-hydrogel-filled vs saline-filled implants.
Review: Different types of implants for reconstructive breast surgery
Comparison: 1 Capsular contracture
Outcome: 3 PVP-hydrogel-filled vs saline-filled implants
Study or subgroup PVP-hydrogel-filled Saline-filled Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Benediktsson 2000 7/20 2/20 3.50 [ 0.83, 14.83 ]
0.01 0.1 1 10 100
Favours PVP-hydrogel Favours saline
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Analysis 1.4. Comparison 1 Capsular contracture, Outcome 4 Anatomical vs round implants.
Review: Different types of implants for reconstructive breast surgery
Comparison: 1 Capsular contracture
Outcome: 4 Anatomical vs round implants
Study or subgroup Anatomical implant Round implant Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gahm 2010 2/18 1/18 2.00 [ 0.20, 20.15 ]
0.01 0.1 1 10 100
Favours anatomical Favours round
Analysis 2.1. Comparison 2 Patient satisfaction, Outcome 1 Silicone-filled vs saline-filled implants: patient
satisfaction for consistency.
Review: Different types of implants for reconstructive breast surgery
Comparison: 2 Patient satisfaction
Outcome: 1 Silicone-filled vs saline-filled implants: patient satisfaction for consistency
Study or subgroup Silicone-filled Saline-filled Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gylbert 1990 17/34 20/24 0.60 [ 0.41, 0.88 ]
0.01 0.1 1 10 100
Favours saline Favours silicone
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Analysis 2.2. Comparison 2 Patient satisfaction, Outcome 2 Silicone-filled vs saline-filled implants: size
decrease.
Review: Different types of implants for reconstructive breast surgery
Comparison: 2 Patient satisfaction
Outcome: 2 Silicone-filled vs saline-filled implants: size decrease
Study or subgroup Silicone-filled Saline-filled Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gylbert 1990 7/34 9/24 0.55 [ 0.24, 1.27 ]
0.01 0.1 1 10 100
Favours silicone Favours saline
Analysis 2.3. Comparison 2 Patient satisfaction, Outcome 3 Variable- vs fixed-volume implants: patient
satisfaction, aesthetic results.
Review: Different types of implants for reconstructive breast surgery
Comparison: 2 Patient satisfaction
Outcome: 3 Variable- vs fixed-volume implants: patient satisfaction, aesthetic results
Study or subgroup Variable-volume Fixed-volume
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Eriksen 2012 20 4.2 (1) 20 5.3 (0.5) -1.10 [ -1.59, -0.61 ]
-10 -5 0 5 10
Favours fixed-volume Favours variable-volume
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Analysis 2.4. Comparison 2 Patient satisfaction, Outcome 4 Variable- vs fixed-volume implants: patient
satisfaction, correspondence to expectations.
Review: Different types of implants for reconstructive breast surgery
Comparison: 2 Patient satisfaction
Outcome: 4 Variable- vs fixed-volume implants: patient satisfaction, correspondence to expectations
Study or subgroup Variable-volume Fixed-volume Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Eriksen 2012 4/20 16/20 0.25 [ 0.10, 0.62 ]
0.02 0.1 1 10 50
Favours fixed-volume Favours variable-volume
Analysis 2.5. Comparison 2 Patient satisfaction, Outcome 5 Variable- vs fixed-volume implants: patient
satisfaction, recommending to others.
Review: Different types of implants for reconstructive breast surgery
Comparison: 2 Patient satisfaction
Outcome: 5 Variable- vs fixed-volume implants: patient satisfaction, recommending to others
Study or subgroup Variable-volume Fixed-volume Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Eriksen 2012 15/20 20/20 0.76 [ 0.58, 0.98 ]
0.1 0.2 0.5 1 2 5 10
Favours fixed-volume Favours variable-volume
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Analysis 3.1. Comparison 3 Short-term complications, Outcome 1 PVP-hydrogel-filled vs saline-filled
implants.
Review: Different types of implants for reconstructive breast surgery
Comparison: 3 Short-term complications
Outcome: 1 PVP-hydrogel-filled vs saline-filled implants
Study or subgroup PVP-hydrogel-filled saline-filled Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Benediktsson 2000 2/20 1/21 2.10 [ 0.21, 21.39 ]
0.01 0.1 1 10 100
Favours PVP hydrogel Favours saline
Analysis 3.2. Comparison 3 Short-term complications, Outcome 2 Anatomical vs round implants.
Review: Different types of implants for reconstructive breast surgery
Comparison: 3 Short-term complications
Outcome: 2 Anatomical vs round implants
Study or subgroup Anatomical implant Round implant Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gahm 2010 4/18 2/18 2.00 [ 0.42, 9.58 ]
0.01 0.1 1 10 100
Favours anatomical Favours round
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Analysis 4.1. Comparison 4 Reintervention, Outcome 1 Textured vs smooth implants.
Review: Different types of implants for reconstructive breast surgery
Comparison: 4 Reintervention
Outcome: 1 Textured vs smooth implants
Study or subgroup Textured implants Smooth implants Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thuesen 1995 2/11 2/9 0.82 [ 0.14, 4.71 ]
0.01 0.1 1 10 100
Favours textured Favours smooth
Analysis 4.2. Comparison 4 Reintervention, Outcome 2 Silicone-filled vs saline-filled implants.
Review: Different types of implants for reconstructive breast surgery
Comparison: 4 Reintervention
Outcome: 2 Silicone-filled vs saline-filled implants
Study or subgroup Silicone-filled Saline-filled
Peto
Odds Ratio
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Gylbert 1990 0/34 6/26 0.08 [ 0.01, 0.43 ]
0.01 0.1 1 10 100
Favours silicone Favours saline
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Analysis 4.3. Comparison 4 Reintervention, Outcome 3 Anatomical vs round implants.
Review: Different types of implants for reconstructive breast surgery
Comparison: 4 Reintervention
Outcome: 3 Anatomical vs round implants
Study or subgroup Anatomical implant Round implant Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gahm 2010 6/18 4/18 1.50 [ 0.51, 4.43 ]
0.01 0.1 1 10 100
Favours anatomical Favours round
Analysis 4.4. Comparison 4 Reintervention, Outcome 4 Variable-volume vs fixed-volume implants.
Review: Different types of implants for reconstructive breast surgery
Comparison: 4 Reintervention
Outcome: 4 Variable-volume vs fixed-volume implants
Study or subgroup Variable-volume Fixed-volume Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Eriksen 2012 14/20 2/20 7.00 [ 1.82, 26.89 ]
0.01 0.1 1 10 100
Favours variable-volume Favours fixed-volume
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Analysis 5.1. Comparison 5 Cosmetic outcomes not reported by participants, Outcome 1 Variable- vs
fixed-volume implants: cosmetic outcomes according to expert panel.
Review: Different types of implants for reconstructive breast surgery
Comparison: 5 Cosmetic outcomes not reported by participants
Outcome: 1 Variable- vs fixed-volume implants: cosmetic outcomes according to expert panel
Study or subgroup Variable-volume Fixed-volume
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Eriksen 2012 20 4 (0.87) 20 4.7 (0.62) -0.70 [ -1.17, -0.23 ]
-10 -5 0 5 10
Favours fixed-volume Favours variable-volume
Analysis 5.2. Comparison 5 Cosmetic outcomes not reported by participants, Outcome 2 Variable- vs
fixed-volume implants: cosmetic outcomes according to lay panel.
Review: Different types of implants for reconstructive breast surgery
Comparison: 5 Cosmetic outcomes not reported by participants
Outcome: 2 Variable- vs fixed-volume implants: cosmetic outcomes according to lay panel
Study or subgroup Variable-volume Fixed-volume
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Eriksen 2012 20 3.2 (1.02) 20 3.5 (0.7) -0.30 [ -0.84, 0.24 ]
-4 -2 0 2 4
Favours fixed-volume Favours variable-volume
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A P P E N D I C E S
Appendix 1. MEDLINE
# Searches
1 randomized controlled trial.pt.
2 controlled clinical trial.pt.
3 randomized.ab.
4 placebo.ab.
5 drug therapy.fs.
6 randomly.ab.
7 trial.ab.
8 groups.ab.
9 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8
10 cohort studies/
11 longitudinal studies/
12 follow-up studies/
13 prospective studies/
14 retrospective studies/
15 cohort.ti,ab.
16 longitudinal.ti,ab.
17 prospective.ti,ab.
18 retrospective.ti,ab.
19 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
20 Case-Control Studies/
21 Control Groups/
22 Matched-Pair Analysis/
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(Continued)
23 retrospective studies/
24 ((case* adj5 control*) or (case adj3 comparison*) or control group*).ti,ab
25 20 or 21 or 22 or 23 or 24
26 exp Breast Neoplasms/
27 (breast adj6 cancer$).mp.
28 (breast adj6 neoplasm$).mp.
29 (breast adj6 carcinoma$).mp.
30 (breast adj6 tumour$).mp.
31 (breast adj6 tumor$).mp.
32 26 or 27 or 28 or 29 or 30 or 31
33 exp Mammaplasty/
34 exp Reconstructive Surgical Procedures/
35 exp Surgery, Plastic/
36 exp *Breast Implants/
37 mammoplasty.mp.
38 mammaplasty.mp.
39 mammoplast*.mp.
40 mammaplast*.mp.
41 breast reconstruction$.mp.
42 breast reconstructive surger$.mp.
43 implant-based breast reconstruction$.mp.
44 exp Silicone Gels/
45 silicone breast implant$.mp.
46 saline breast implant$.mp.
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(Continued)
47 saline-filled breast implant$.mp.
48 texturi#ed implant.mp.
49 smooth implant.mp.
50 implant envelope surface.mp.
51 variable volume implant.mp.
52 fixed volume implant.mp.
53 texturi#ation.mp.
54 (implant$ adj5 breast reconstruction).mp.
55 (implant$ adj5 breast reconstructive surger$).mp.
56 (silicone adj5 breast implant$).mp.
57 (saline adj5 breast implant$).mp.
58 (texturi#ed adj5 implant$).mp.
59 (smooth adj5 implant$).mp.
60 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or
54 or 55 or 56 or 57 or 58 or 59
61 32 and 60
62 autologous tissue breast reconstruction.mp.
63 autologous tissue-based breast reconstruction.mp.
64 (autologous tissue adj5 breast reconstruct*).mp.
65 autologous reconstruction.mp.
66 Breast reconstruction with autologous tissue.mp.
67 autogenous tissue breast reconstruction.mp.
68 (autogenous tissues adj5 breast reconstruct*).mp.
69 autologous fat graft*.mp.
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(Continued)
70 (autologous adj5 fat graft*).mp.
71 autogenous fat graft*.mp.
72 (autogenous adj5 fat graft*).mp.
73 autologous fat transplant*.mp.
74 (autologous adj5 fat transplant*).mp.
75 autogenous fat transplant*.mp.
76 (autogenous adj5 fat transplant*).mp.
77 latissimus dorsi musculocutaneous flap.mp.
78 Transverse Rectus Abdominis Myocutaneous flap.mp.
79 TRAM flap.mp.
80 DIEP.mp.
81 SIEP.mp.
82 TRAM.mp.
83 deep inferior epigastric perforator flap.mp.
84 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78 or 79 or 80 or 81 or 82 or 83
85 61 not 84
86 Animals/ not Humans/
87 85 not 86
88 9 and 87
89 19 and 87
90 25 and 87
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Appendix 2. EMBASE
1. random* OR factorial* OR crossover*OR cross NEXT/1 over* OR placebo* OR (doubl* AND blind*) OR (singl* AND
blind*) OR assign*AND allocat* OR volunteer* OR ’crossover procedure’/exp OR ’double blind procedure’/exp OR
’randomized controlled trial’/exp OR’single blind procedure’/exp
2. (cohortOR concurrent OR incidence OR longitudinal OR followup OR ’follow up’ OR prospective OR retrospective)
NEXT/1 (analys*OR design* OR evaluation* OR research OR stud* OR survey* OR trial*) OR ’prospective method’/exp OR
’retrospective study’/syn
3. ’case control study’/syn OR (’case control’OR ’case base’ OR ’case matched’ OR retrospective) NEXT/3 (analys* OR
design* ORevaluation* OR research OR stud* OR survey* OR trial*)
4. ’breast’/exp OR ’breast disease’/exp AND ’neoplasm’/exp OR ’breast tumor’/exp OR (breast* NEAR/5 neoplas*):ab,ti OR
(breast* NEAR/5cancer*):ab,ti OR (breast* NEAR/5 carcin*):ab,ti OR (breast* NEAR/5 tumo*):ab,ti OR (breast* NEAR/5
metasta*):ab,ti OR (breast* NEAR/5malig*):ab,ti
5. ’breast reconstruction’/exp OR ’breast reconstruction’
6. ’mammaplasty’/exp OR mammaplasty
7. ’mammoplasty’/exp OR mammoplasty
8. ’plastic surgery’/exp OR ’plastic surgery’
9. ’breast implant’/exp OR ’breast implant’
10. ’breast reconstructive surgery’
11. ’implant-based breast reconstruction’
12. ’silicone gel’/exp OR ’silicone gel’
13. ’silicone breast implant’/exp OR ’silicone breast implant’
14. ’saline breast implant’
15. ’saline-filled breast implant’
16. ’texturized implant’
17. ’texturised implant’
18. ’smooth implant’
19. ’implant envelope surface’
20. ’variable volume implant’
21. ’fixed volume implant’
22. texturization
23. texturisation
24. implant NEAR/5 ’breast reconstruction’
25. implant NEAR/5 ’breast reconstructive surgery’
26. silicone NEAR/5 ’breast implant’
27. saline NEAR/5 ’breast implant’
28. texturized NEAR/5 implant
29. texturised NEAR/5 implant
30. smooth NEAR/5 implant
31. #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14OR #15 OR #16 OR #17 OR #18 OR #19 OR
#20 OR #21 OR #22 OR#23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30
32. #4 AND #31
33. ’autologous tissue breast reconstruction’
34. ’autologous tissue-based breast reconstruction’
35. ’autologous tissue’ NEAR/5 ’breast reconstruction’
36. ’autologous reconstruction’
37. ’breast reconstruction with autologous tissue’
38. ’autogenous tissue breast reconstruction’
39. ’autogenous tissues’ NEAR/5 ’breast reconstruction’
40. ’autologous fat graft’
41. autologous NEAR/5 ’fat graft’
42. ’autogenous fat graft’
43. autogenous NEAR/5 ’fat graft’
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44. ’autologous fat transplant’
45. autologous NEAR/5 ’fat transplant’
46. ’autogenous fat transplant’
47. autogenous NEAR/5 ’fat transplant’
48. ’latissimus dorsi musculocutaneous flap’/exp OR ’latissimus dorsi musculocutaneous flap’
49. ’transverse rectus abdominis myocutaneous flap’/exp OR ’transverse rectus abdominis myocutaneous flap’
50. ’tram flap’/exp OR ’tram flap’
51. diep
52. siep
53. ’deep inferior epigastric perforator flap’/exp OR ’deep inferior epigastric perforator flap’
54. #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #
47 OR #48 OR #49 OR#50 OR #51 OR #52 OR #53 OR #54
55. #32 NOT #55
56. #56 NOT ([animals]/lim NOT [humans]/lim)
57. #1 AND #57
58. #2 AND #57
59. #3 AND #57
Appendix 3. CENTRAL
#1 MeSH descriptor: [Breast Neoplasms] explode all trees
#2 breast cancer* or breast neoplasm*
#3 #1 or #2
#4 MeSH descriptor: [Mammaplasty] explode all trees
#5 MeSH descriptor: [Reconstructive Surgical Procedures] explode all trees
#6 MeSH descriptor: [Surgery, Plastic] explode all trees
#7 MeSH descriptor: [Prostheses and Implants] explode all trees
#8 mammoplast*
#9 mammaplast*
#10 breast reconstruction*
#11 breast reconstructive surger*
#12 implant-based breast reconstruction*
#13 MeSH descriptor: [Breast Implants] explode all trees
#14 MeSH descriptor: [Silicone Gels] explode all trees
#15 silicone breast implant*
#16 saline breast implant*
#17 saline-filled breast implant*
#18 texturised implant or texturized implant
#19 smooth implant
#20 implant envelope surface
#21 variable volume implant
#22 fixed volume implant
#23 implant and breast reconstruct*
#24 #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or
#23
#25 #3 and #24
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Appendix 4. WHO ICTRP search portal
Basic Searches:
1. Different types of implants for reconstructive breast surgery
2. breast cancer AND implant
3. reconstructive breast surgery AND implant
4. breast reconstruction and implant
5. mammoplasty AND breast implant
6. mammaplasty AND breast implant
Advanced Searches:
1. Title: Different types of implants for reconstructive breast surgery
Recruitment Status: ALL
2. Condition: breast cancer
Intervention: implant AND (reconstructive breast surgery OR breast reconstruction)
Recruitment Status: ALL
3. Condition: breast cancer
Intervention: (silicone OR saline) AND breast implant
Recruitment Status: ALL
4. Condition: breast cancer
Intervention: implant-based breast reconstruction OR mammoplasty OR mammaplasty
Recruitment Status: ALL
Appendix 5. Clinicaltrials.gov
Basic Searches:
1. Different types of implants for reconstructive breast surgery
2. breast cancer AND implant
3. reconstructive breast surgery AND implant
4. breast reconstruction and implant
5. mammoplasty AND breast implant
6. mammaplasty AND breast implant
Advanced Searches:
1. Title: Different types of implants for reconstructive breast surgery
Recruitment Status: All Studies
Study Results: All Studies
Study Type: All Studies
Gender: All Studies
2. Condition: breast cancer
Intervention: implant AND (reconstructive breast surgery OR breast reconstruction)
Recruitment Status: All Studies
Study Results: All Studies
Study Type: All Studies
Gender: All Studies
3. Condition: breast cancer
Intervention: (silicone OR saline) AND breast implant
Recruitment Status: All Studies
Study Results: All Studies
Study Type: All Studies
Gender: All Studies
4. Condition: breast cancer
Intervention: implant-based breast reconstruction OR mammoplasty OR mammaplasty
Recruitment Status: All Studies
Study Results: All Studies
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Study Type: All Studies
Gender: All Studies
C O N T R I B U T I O N S O F A U T H O R S
Drafting of the protocol: NR, CR, BA, AA
Study selection: NR, CR, LI, MBN
Disagreement resolution: NR, ST, LI
Data analysis: CR, LM, AS, GC
D E C L A R A T I O N S O F I N T E R E S T
N Rocco: none known
C Rispoli: none known
L Moja: none known
B Amato: none known
L Iannone: none known
S Testa: none known
A Spano: none known
G Catanuto: none known
A Accurso: none known
MB Nava: none known
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support, Other.
External sources
• No sources of support, Other.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Two comparisons have been added in this review since publication of the protocol:
1. Implant filler material: PVP-hydrogel-filled versus saline-filled implants
2. Implant shape: anatomical versus round.
We used odds ratios to report estimates effect size for one comparison (silicone- versus saline-filled implants for the outcome reinter-
vention) instead of relative risk due to the presence of zero events in one group.
In line with Cochrane conduct standards, the GRADE approach was used to assess the quality of evidence for the outcomes reported.
Summary of Findings tables were created using GRADEproGDT software.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Mammaplasty; Breast Implants [∗classification]; Breast Neoplasms [∗surgery]; Hydrogels; Mastectomy; Patient Satisfaction; Prophy-
lactic Surgical Procedures; Prosthesis Failure; Randomized Controlled Trials as Topic; Silicone Gels; Sodium Chloride
MeSH check words
Female; Humans; Middle Aged
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